Heat Biologics, Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including a novel COVID-19 vaccine and multiple oncology product candidates, announced further progress on its COVID-19 vaccine program.
June 5, 2020
· 4 min read